Calidad de vida en pacientes con cáncer de pulmón

Guardado en:

2256-2877

2256-2915

8

2021-10-01

7

9

http://purl.org/coar/access_right/c_abf2

info:eu-repo/semantics/openAccess

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Revista Colombiana de Hematología y Oncología - 2021

id a68bec2641d19bfb598eef5798509e7d
record_format ojs
institution ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png
country_str Colombia
collection Revista Colombiana de Hematología y Oncología
title Calidad de vida en pacientes con cáncer de pulmón
spellingShingle Calidad de vida en pacientes con cáncer de pulmón
Yepes Pérez , Andrés
Calidad de vida
cáncer de pulmón
title_short Calidad de vida en pacientes con cáncer de pulmón
title_full Calidad de vida en pacientes con cáncer de pulmón
title_fullStr Calidad de vida en pacientes con cáncer de pulmón
title_full_unstemmed Calidad de vida en pacientes con cáncer de pulmón
title_sort calidad de vida en pacientes con cáncer de pulmón
title_eng Quality of life in patients with lung cancer
author Yepes Pérez , Andrés
author_facet Yepes Pérez , Andrés
topicspa_str_mv Calidad de vida
cáncer de pulmón
topic Calidad de vida
cáncer de pulmón
topic_facet Calidad de vida
cáncer de pulmón
citationvolume 8
citationissue 1
citationedition Núm. 1 , Año 2021 : Enero-Junio
publisher Asociación Colombiana de Hematología y Oncología (ACHO)
ispartofjournal Revista Colombiana de Hematología y Oncología
source https://revista.acho.info/index.php/acho/article/view/377
language Español
format Article
rights http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Revista Colombiana de Hematología y Oncología - 2021
https://creativecommons.org/licenses/by-nc-nd/4.0
references World Health Organization [Internet]. Lyon: International Agency for Research on Cancer. The Global Cancer Observatory. World fact sheet: Cancer; 2021 March [Consultado 9 agosto 2021]; Disponible en: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975-2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute. Disponible en: https://seer.cancer.gov/csr/1975_2016/ 3. Koller M, Shamieh O, Hjermstad MJ, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. [Internet]. 2020;21(5):723-732. Disponible en: https://doi.org/10.1016/S1470-2045(20)30093-0 4. Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Natl Cancer Inst. [Internet]. 2019;111:1279-1297. Disponible en: https://doi.org/1093/jnci/djz106 5. Hardtstock, F., Myers, D., Li, T. et al. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis. BMC Cancer. [Internet]. 2020;20:260-274. Disponible en: https://doi.org/10.1186/s12885-020-06738-z 6. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. [Internet]. 2016;9:1023-1028. Disponible en: https://doi.org/10.2147/OTT.S100685 7. Lemonnier I, Guillemin F, Arveux P, Clément-Duchêne C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of nonsmall cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. [Internet]. 2014;12:73. Disponible en: https://doi.org/10.1186/1477-7525-12-73 8. Van Der Weijst L, Lievens Y, Schrauwen W and Surmont V. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review. Front. Oncol. [Internet]. 2019;9:715. Disponible en: https://doi.org/10.3389/fonc.2019.00715 9. Reale ML, Di Maio M. Quality of life in patients with lung cancer: the way forward. Lancet Oncol. [Internet]. 2020;21:617-619. Disponible en: https://doi.org/10.1016/S1470-2045(20)30151-0 10. Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. [Internet]. 2013;81(2):288–293. Disponible en: https://doi.org/10.1016/j.lungcan.2013.03.008 11. Bdira B, Aissa S, Houda R, Benzarti W, Knaz A, Hayouni A, Abdelghani A, Garrouch A, Benzarti M, Gargouri I. Factors associated with altered quality of life among lung cancer patients. Eur Respir J. [Internet]. 2019;54 (suppl 63) PA4655. Disponible en: https://doi.org/10.1183/13993003.congress-2019.PA4655 12. Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol. [Internet]. 2006;24:3831–3837. Disponible en: https://doi.org/10.1200/JCO.2006.05.8073 13. Reck M, Wehler T, Orlandi F, et al. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol. [Internet]. 2020;38:2530-2542. Disponible en: https://doi.org/10.1200/JCO.19.03158 14. Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. [Internet]. 2020;31(1):96-102. Disponible en: https://doi.org/10.1016/j.annonc.2019.10.006 15. Ramsey S, Bansal A, Fedorenko C, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980e986. Disponible en: https://doi.org/10.1200/JCO.2015.64.6620
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_b239
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2021-10-01
date_accessioned 2021-10-01T19:10:11Z
date_available 2021-10-01T19:10:11Z
url https://revista.acho.info/index.php/acho/article/view/377
url_doi https://doi.org/10.51643/22562915.377
issn 2256-2877
eissn 2256-2915
doi 10.51643/22562915.377
citationstartpage 7
citationendpage 9
url2_str_mv https://revista.acho.info/index.php/acho/article/download/377/359
_version_ 1797159783298498560
spelling Calidad de vida en pacientes con cáncer de pulmón
https://revista.acho.info/index.php/acho/article/view/377
Text
http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/publishedVersion
http://purl.org/redcol/resource_type/ARTEDIT
http://purl.org/coar/resource_type/c_b239
http://purl.org/coar/resource_type/c_6501
info:eu-repo/semantics/article
World Health Organization [Internet]. Lyon: International Agency for Research on Cancer. The Global Cancer Observatory. World fact sheet: Cancer; 2021 March [Consultado 9 agosto 2021]; Disponible en: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975-2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute. Disponible en: https://seer.cancer.gov/csr/1975_2016/ 3. Koller M, Shamieh O, Hjermstad MJ, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. [Internet]. 2020;21(5):723-732. Disponible en: https://doi.org/10.1016/S1470-2045(20)30093-0 4. Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Natl Cancer Inst. [Internet]. 2019;111:1279-1297. Disponible en: https://doi.org/1093/jnci/djz106 5. Hardtstock, F., Myers, D., Li, T. et al. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis. BMC Cancer. [Internet]. 2020;20:260-274. Disponible en: https://doi.org/10.1186/s12885-020-06738-z 6. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. [Internet]. 2016;9:1023-1028. Disponible en: https://doi.org/10.2147/OTT.S100685 7. Lemonnier I, Guillemin F, Arveux P, Clément-Duchêne C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of nonsmall cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. [Internet]. 2014;12:73. Disponible en: https://doi.org/10.1186/1477-7525-12-73 8. Van Der Weijst L, Lievens Y, Schrauwen W and Surmont V. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review. Front. Oncol. [Internet]. 2019;9:715. Disponible en: https://doi.org/10.3389/fonc.2019.00715 9. Reale ML, Di Maio M. Quality of life in patients with lung cancer: the way forward. Lancet Oncol. [Internet]. 2020;21:617-619. Disponible en: https://doi.org/10.1016/S1470-2045(20)30151-0 10. Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. [Internet]. 2013;81(2):288–293. Disponible en: https://doi.org/10.1016/j.lungcan.2013.03.008 11. Bdira B, Aissa S, Houda R, Benzarti W, Knaz A, Hayouni A, Abdelghani A, Garrouch A, Benzarti M, Gargouri I. Factors associated with altered quality of life among lung cancer patients. Eur Respir J. [Internet]. 2019;54 (suppl 63) PA4655. Disponible en: https://doi.org/10.1183/13993003.congress-2019.PA4655 12. Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol. [Internet]. 2006;24:3831–3837. Disponible en: https://doi.org/10.1200/JCO.2006.05.8073 13. Reck M, Wehler T, Orlandi F, et al. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol. [Internet]. 2020;38:2530-2542. Disponible en: https://doi.org/10.1200/JCO.19.03158 14. Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. [Internet]. 2020;31(1):96-102. Disponible en: https://doi.org/10.1016/j.annonc.2019.10.006 15. Ramsey S, Bansal A, Fedorenko C, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980e986. Disponible en: https://doi.org/10.1200/JCO.2015.64.6620
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Revista Colombiana de Hematología y Oncología - 2021
https://creativecommons.org/licenses/by-nc-nd/4.0
Español
Publication
Yepes Pérez , Andrés
Revista Colombiana de Hematología y Oncología
Asociación Colombiana de Hematología y Oncología (ACHO)
application/pdf
Calidad de vida
cáncer de pulmón
8
1
Núm. 1 , Año 2021 : Enero-Junio
Artículo de revista
Journal article
Quality of life in patients with lung cancer
2256-2915
https://revista.acho.info/index.php/acho/article/download/377/359
2021-10-01T19:10:11Z
2256-2877
2021-10-01T19:10:11Z
9
7
2021-10-01
https://doi.org/10.51643/22562915.377
10.51643/22562915.377